Clinical and Biomedical Sciences: Recent submissions
Now showing items 56-60 of 330
-
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer
(Springer Nature, 5 March 2024)Hereditary Breast and Ovarian Cancer (HBOC) is a genetic condition associated with increased risk of cancers. The past decade has brought about significant changes to hereditary breast and ovarian cancer (HBOC) diagnostic ... -
Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practice
(Springer Nature, 4 June 2024)BACKGROUND: The CanRisk tool, which operationalises the Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) is used by Clinical Geneticists, Genetic Counsellors, Breast Oncologists, ... -
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach
(Springer, 5 June 2024)AIMS/HYPOTHESIS: Older adults are under-represented in trials, meaning the benefits and risks of glucose-lowering agents in this age group are unclear. The aim of this study was to assess the safety and effectiveness of ... -
Challenges of detecting childhood diabetes in primary care
(Elsevier, 22 May 2024) -
Prospective, International, Multisite Comparison of Platelet Isolation Techniques for Genome-Wide Transcriptomics: Communication from the SSC of the ISTH
(Elsevier / International Society on Thrombosis and Haemostasis, 3 July 2024)Genome-wide platelet transcriptomics is increasingly used to uncover new aspects of platelet biology and as a diagnostic and prognostic tool. Nevertheless, platelet isolation methods for transcriptomic studies are not ...